APA (7th ed.) Citation

Kang, Y., Kim, H., Yook, J. H., Park, Y., Lee, J. S., Kim, Y., . . . Kang, S. Y. (2024). Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY. Journal of Clinical Oncology, 42(25), 2961-2968. https://doi.org/10.1200/JCO.23.02167

Chicago Style (17th ed.) Citation

Kang, Yoon-Koo, et al. "Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY." Journal of Clinical Oncology 42, no. 25 (2024): 2961-2968. https://doi.org/10.1200/JCO.23.02167.

MLA (8th ed.) Citation

Kang, Yoon-Koo, et al. "Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY." Journal of Clinical Oncology, vol. 42, no. 25, 2024, pp. 2961-2968, https://doi.org/10.1200/JCO.23.02167.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.